Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/HEP.0000000000000889 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply: On the use of nonselective beta blockers in cirrhosis.
Hepatology
August 2024
Department of Medicine, Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension. Authors' reply.
Aliment Pharmacol Ther
July 2022
Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK.
Letter: hepatocellular carcinoma risk in patients with non-selective beta blockers-authors' reply.
Aliment Pharmacol Ther
October 2021
School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Reply to: "Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?".
J Hepatol
October 2021
Department of Gastroenterology, Hospital Santa Creu i Sant Pau, Barcelona, Spain; Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Barcelona, Spain. Electronic address:
Editorial: non-selective beta blockers-in and out of circulation. Authors' reply.
Aliment Pharmacol Ther
March 2021
Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!